EGFR and neoplasm: In addition, EGFR/EGFRvIII signaling maintains GBM cancer stem cells (CSCs) also called side population (SP) [17–19] and control tumor progression, recurrence, and resistance to chemoradiation therapy (CRT) [20, 21].